Company Profile_ Shanghai Chenguang Medical Technology Co., Ltd.
>
Company Profile
All categories

Company Profile

  • Categories:About Us
  • Time of issue:2020-01-09 00:00:00
  • Views:0
Description:        上海辰光医疗科技股份有限公司(证券简称:辰光医疗,证券代码:430300)2004年成立,注册资本6859.7126万元,是一家长期致力于高场强和超高场强磁共振产业链的核心部件的研发、生产、销售和维修的自主创新型高新技术企业和上海市小巨人企业。现有员工约230余名,其中,博士6人,硕士8人。公司在上海张江高新产业开发区青浦园区拥有逾34000平方米的高灵敏度磁共振核心部件研发和生产基地。旗下三家子公司,分别为辰时医疗、辰瞻医疗、和辰昊超导。产品覆盖磁共振(1.5T、3.0T、7.0T)的射频系统、梯度系统、超导磁体等核心部件,和超导、常导磁体、低温设备、真空半导体设备等。        辰光医疗的项目带头人有丰富的在海内外从事超导磁共振核心部件的开发、设计和生产的经验,由他们设计生产的磁共振核心部件已配套应用于国内、外主流MRI企业生产的磁共振系统上。辰光医疗自主研发生产的磁共振射频探测器在进入中国医疗器械产品注册时填补了国内空白,公司还首创为尖端科研定制开发了多种实验专用射频线圈。辰光医疗以领先的综合工程化能力为依托,经过多年的研发积累,先后攻克了1.5T、3.0T和7.0T磁共振系统中多个核心部件技术难关,现有80余项专利技术均应用于磁共振核心部件的研发和生产中,产品打破了国际同类产品在中国的垄断地位,成功实现了进口替代。公司为中国磁共振系统商提供的MR平台解决方案可比肩知名跨国磁共振系统。        辰光医疗致力于合法合规经营,搭建了先进的质量体系规范,并获得了国内、国际市场的准入资质。公司先后通过了ISO13485,ISO14001和欧洲CE认证。我们自主研发的核心产品通过了中国食品药品监督管理局SFDA认证和UL安全认证,同时,出口欧、美、日等国家的产品还具备美国食品药品监督管理局FDA认证和日本PAL等国际认证。        辰光医疗将不断提升公司在超导磁共振射频探测器、超导磁体等领域的先进地位,逐步拓展超导磁共振的产业链和应用领域,由部件生产商向多元化生产和服务型企业转型,努力将“辰光医疗”打造成为与跨国企业媲美的中国磁共振品牌。
Description:        上海辰光医疗科技股份有限公司(证券简称:辰光医疗,证券代码:430300)2004年成立,注册资本6859.7126万元,是一家长期致力于高场强和超高场强磁共振产业链的核心部件的研发、生产、销售和维修的自主创新型高新技术企业和上海市小巨人企业。现有员工约230余名,其中,博士6人,硕士8人。公司在上海张江高新产业开发区青浦园区拥有逾34000平方米的高灵敏度磁共振核心部件研发和生产基地。旗下三家子公司,分别为辰时医疗、辰瞻医疗、和辰昊超导。产品覆盖磁共振(1.5T、3.0T、7.0T)的射频系统、梯度系统、超导磁体等核心部件,和超导、常导磁体、低温设备、真空半导体设备等。        辰光医疗的项目带头人有丰富的在海内外从事超导磁共振核心部件的开发、设计和生产的经验,由他们设计生产的磁共振核心部件已配套应用于国内、外主流MRI企业生产的磁共振系统上。辰光医疗自主研发生产的磁共振射频探测器在进入中国医疗器械产品注册时填补了国内空白,公司还首创为尖端科研定制开发了多种实验专用射频线圈。辰光医疗以领先的综合工程化能力为依托,经过多年的研发积累,先后攻克了1.5T、3.0T和7.0T磁共振系统中多个核心部件技术难关,现有80余项专利技术均应用于磁共振核心部件的研发和生产中,产品打破了国际同类产品在中国的垄断地位,成功实现了进口替代。公司为中国磁共振系统商提供的MR平台解决方案可比肩知名跨国磁共振系统。        辰光医疗致力于合法合规经营,搭建了先进的质量体系规范,并获得了国内、国际市场的准入资质。公司先后通过了ISO13485,ISO14001和欧洲CE认证。我们自主研发的核心产品通过了中国食品药品监督管理局SFDA认证和UL安全认证,同时,出口欧、美、日等国家的产品还具备美国食品药品监督管理局FDA认证和日本PAL等国际认证。        辰光医疗将不断提升公司在超导磁共振射频探测器、超导磁体等领域的先进地位,逐步拓展超导磁共振的产业链和应用领域,由部件生产商向多元化生产和服务型企业转型,努力将“辰光医疗”打造成为与跨国企业媲美的中国磁共振品牌。
Information

        Shanghai Chenguang Medical Technology Co., Ltd. (stock abbreviation: Chenguang Medical, stock code: 430300) was established in 2004 with a registered capital of 68,597,126 million yuan. It is a company dedicated to the core components of the high-field and ultra-high-field magnetic resonance industry chain for a long time. Independent and innovative high-tech enterprises in R&D, production, sales and maintenance, and small giant enterprises in Shanghai. There are about 230 employees, including 6 doctors and 8 masters. The company has over 34,000 square meters of high-sensitivity magnetic resonance core components R&D and production base in Qingpu Park, Zhangjiang High-tech Industrial Development Zone, Shanghai. Its three subsidiaries are Chenshi Medical, Chenzhan Medical, and Chenhao Superconductor. The products cover the core components of magnetic resonance (1.5T, 3.0T, 7.0T) radio frequency systems, gradient systems, superconducting magnets, and superconducting, normally conductive magnets, cryogenic equipment, vacuum semiconductor equipment, etc.

        The project leaders of Chenguang Medical have rich experience in the development, design and production of superconducting magnetic resonance core components at home and abroad. The magnetic resonance core components designed and produced by them have been used in the magnetics produced by domestic and foreign mainstream MRI companies. On the resonance system. The magnetic resonance radio frequency detector independently developed and produced by Chenguang Medical filled the domestic gap when it entered the Chinese medical device product registration. The company also pioneered the development of a variety of experimental special radio frequency coils for cutting-edge scientific research. Relying on its leading comprehensive engineering capabilities, after years of research and development, Chenguang Medical has overcome technical difficulties in multiple core components in the 1.5T, 3.0T and 7.0T magnetic resonance systems. Currently, more than 80 patented technologies are applied In the research and development and production of core components of magnetic resonance, the products have broken the monopoly of similar international products in China and successfully realized import substitution. The MR platform solutions provided by the company for Chinese MRI system vendors are comparable to well-known multinational MRI systems.

        Chenguang Medical is committed to operating in compliance with laws and regulations, has established advanced quality system specifications, and has obtained the qualifications for domestic and international market access. The company has passed ISO13485, ISO14001 and European CE certification. Our self-developed core products have passed the China Food and Drug Administration SFDA certification and UL safety certification. At the same time, products exported to Europe, the United States, Japan and other countries also have the US Food and Drug Administration FDA certification and Japan PAL certification.

        Chenguang Medical will continue to enhance the company's advanced position in the fields of superconducting magnetic resonance radio frequency detectors, superconducting magnets, etc., and gradually expand the industry chain and application fields of superconducting magnetic resonance, and transform from a component manufacturer to a diversified production and service enterprise , And strive to build "Chenguang Medical" into a Chinese MRI brand comparable to multinational companies.

 

Scan the QR code to read on your phone

Copyright   上海辰光医疗科技股份有限公司     沪ICP备08006789号-7  技术支持:中企动力   上海